Trials / Completed
CompletedNCT01789619
Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (actual)
- Sponsor
- UMC Utrecht · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the clinical efficacy of the extended release formulation of tacrolimus (Advagraf®) in patients with severe atopic dermatitis, who can not be treated adequately with cyclosporine A because of side effects and/or non-responsiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Extended release tacrolimus (Advagraf®) |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2013-02-12
- Last updated
- 2015-05-29
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01789619. Inclusion in this directory is not an endorsement.